542 related articles for article (PubMed ID: 29617404)
21. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
22. MiR-126 Modulates Angiogenesis in Breast Cancer by Targeting VEGF-A -mRNA.
Alhasan L
Asian Pac J Cancer Prev; 2019 Jan; 20(1):193-197. PubMed ID: 30678431
[TBL] [Abstract][Full Text] [Related]
23. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
[TBL] [Abstract][Full Text] [Related]
24. Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.
Jardim-Perassi BV; Lourenço MR; Doho GM; Grígolo IH; Gelaleti GB; Ferreira LC; Borin TF; Moschetta MG; Pires de Campos Zuccari DA
Anticancer Agents Med Chem; 2016; 16(3):347-58. PubMed ID: 25963143
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.
Zhang L; Lv Z; Xu J; Chen C; Ge Q; Li P; Wei D; Wu Z; Sun X
FEBS J; 2018 Apr; 285(7):1359-1371. PubMed ID: 29474747
[TBL] [Abstract][Full Text] [Related]
26. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
[TBL] [Abstract][Full Text] [Related]
27. MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.
Hulin JA; Tommasi S; Elliot D; Hu DG; Lewis BC; Mangoni AA
Sci Rep; 2017 Oct; 7(1):13996. PubMed ID: 29070803
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
[TBL] [Abstract][Full Text] [Related]
29. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
[TBL] [Abstract][Full Text] [Related]
30. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
Salajegheh A; Vosgha H; Md Rahman A; Amin M; Smith RA; Lam AK
J Mol Endocrinol; 2015 Dec; 55(3):183-96. PubMed ID: 26342107
[TBL] [Abstract][Full Text] [Related]
31. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer.
Zhao L; Zhao Y; He Y; Li Q; Mao Y
Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355
[TBL] [Abstract][Full Text] [Related]
32. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
33. Angelol-A exerts anti-metastatic and anti-angiogenic effects on human cervical carcinoma cells by modulating the phosphorylated-ERK/miR-29a-3p that targets the MMP2/VEGFA axis.
Ying TH; Lin CL; Chen PN; Wu PJ; Liu CJ; Hsieh YH
Life Sci; 2022 May; 296():120317. PubMed ID: 35026214
[TBL] [Abstract][Full Text] [Related]
34. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
35. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
[TBL] [Abstract][Full Text] [Related]
36. Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells.
Walz JM; Wecker T; Zhang PP; Cakir B; Gruening B; Agostini H; Reuer T; Ludwig F; Boneva S; Faerber L; Lange C; Schlunck GR; Stahl A
Exp Eye Res; 2019 Apr; 181():98-104. PubMed ID: 30615884
[TBL] [Abstract][Full Text] [Related]
37. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
[TBL] [Abstract][Full Text] [Related]
39. miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells.
Liang H; Ge F; Xu Y; Xiao J; Zhou Z; Liu R; Chen C
Angiogenesis; 2018 Nov; 21(4):849-860. PubMed ID: 29959560
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.
Sun X; Wei L; Chen Q; Terek RM
Clin Orthop Relat Res; 2015 Mar; 473(3):907-13. PubMed ID: 25106798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
